Funding for this research was provided by:
Sparrow Pharmaceuticals, Inc
Article History
Accepted: 9 June 2023
First Online: 15 July 2023
Declarations
:
: The work was supported by Sparrow Pharmaceuticals, Inc.
: David A. Katz is a Sparrow Pharmaceuticals employee, officer, and shareholder, and Guohua An is a consultant of Sparrow Pharmaceuticals, Inc. Nan Wu declares no potential conflicts of interest that might be relevant to the contents of this manuscript.
: Conception and design of the work: GA, DAK. Analysis of the data: NW, GA. Interpretation of the data: GA, NW, DAK. Drafting and critical revision of the manuscript: GA, NW, DAK.
: Not applicable as the current work was a secondary data analysis.
: Not applicable.
: Not applicable.
: Not applicable<b>.</b>
: The datasets generated and analyzed during the current study are proprietary and will not be made available to other investigators.